Publications

• Elsharkawy, M., Sharafeldeen A., Khalifa F., Soliman A., et al. A clinically explainable AI-based grading system for age-related macular degeneration using optical coherence tomography. IEEE Journal of Biomedical and Health Informatics (JBHI), 28(4):2079–2090, 2024.
  First Author Top Journal OCT DOI
• Elsharkawy, M., Sharafeldeen A., Soliman A., Khalifa F., et al. A novel computer-aided diagnostic system for early detection of diabetic retinopathy using 3D-OCT higher-order spatial appearance model. Diagnostics, 12(2):461, 2022.
  First Author Journal 3D-OCT DR
• Elsharkawy, M., Elrazzaz M., Ghazal M., et al. Role of optical coherence tomography imaging in predicting progression of age-related macular disease: A survey. Diagnostics, 11(12):2313, 2021.
  First Author Journal Survey AMD
• Elsharkawy, M., Abdelhalim I., Mahmoud A., Gamal A., et al. Fused-AETNet: A variational transformer-based framework for diabetic retinopathy classification using OCT biomarkers. IEEE Access, 2025.
  First Author Journal Transformer OCT biomarkers
• Elsharkawy, M., Sharafeldeen A., Taher F., et al. Early assessment of lung function in coronavirus patients using invariant markers from chest X-rays images. Scientific Reports, 11(1):12095, 2021.
  First Author High-Visibility Journal CXR COVID-19
• Elsharkawy, M., Elrazzaz M., Sharafeldeen A., et al. The role of different retinal imaging modalities in predicting progression of diabetic retinopathy: A survey. Sensors, 22(9):3490, 2022.
  First Author Journal Survey DR

(This section is intentionally “selected + ordered”. The complete list is on Google Scholar.)

• Elsharkawy, M., Abdelhalim I., Taher F., et al. CrossDR: Bridging 2D and 3D features for diabetic retinopathy classification using context-aware cross-attention. IEEE International Conference on Image Processing (ICIP), 2025.
  First Author Major IEEE Conf Cross-attention 2D+3D
• Elsharkawy, M., Abdelhalim I., Ghazal M., et al. TransNetOCT: An efficient transformer-based model for 3D-OCT segmentation using prior shape. International Conference on Pattern Recognition (ICPR), 2024.
  First Author Major PR Conf Segmentation 3D-OCT
• Elsharkawy, M., Abdelhalim I., Ghazal M., Mahmoud A., Sandhu H.S., El-Baz A. ISGM-DR: Important slice-guided model for diabetic retinopathy diagnosis using 3D-OCT images. IEEE ISBI, 2025.
  First Author Top Biomedical Imaging 3D-OCT
• Elsharkawy, M., Abdelhalim I., Ghazal M., Mahmoud A., et al. OCT-Trans: A novel transformer backbone with multimodal feature extraction in OCT-based retinal disease classification. IEEE ISBI, 2025.
  First Author Top Biomedical Imaging Transformer OCT
• Elsharkawy, M., Sharafeldeen A., Soliman A., et al. Diabetic retinopathy diagnostic CAD system using 3D-OCT higher-order spatial appearance model. IEEE ISBI, 2022.
  First Author Top Biomedical Imaging 3D-OCT

• Saleh I., El-Den N.N., Elsharkawy, M., et al. AI-based methods for diagnosing and grading diabetic retinopathy: A comprehensive review. Artificial Intelligence in Medicine, 2025.
  Top Review Venue DR Survey
• El-Den N.N., Elsharkawy, M., Saleh I., et al. AI-based methods for detecting and classifying age-related macular degeneration: A comprehensive review. Artificial Intelligence Review, 57(9):237, 2024.
  High-Impact Review AMD Survey

• Elsharkawy, M., Sharafeldeen A., Soliman A., et al. Early identification of diabetic retinopathy through a computer-assisted diagnostic system and a higher-order spatial appearance model of 3D-OCT. Photo Acoustic and Optical Coherence Tomography Imaging (Vol. 1), IOP Publishing, 2023.
  First Author Book Chapter DR 3D-OCT
• Elsharkawy, M., Soliman A., Mahmoud A., et al. Prevention of age-related macular degeneration disease: current strategies and future directions. Photo Acoustic and Optical Coherence Tomography Imaging (Vol. 1), IOP Publishing, 2023.
  First Author Book Chapter AMD

• El-Baz A.S., Shalaby A., Elsharkawy, M., et al. Assessment of pulmonary function in coronavirus patients. US Patent 12,217,432, Feb 2025.
  Patent Inventor

If you want: I can add the patent number as a clickable link to the USPTO page.

I kept this section short (only higher-impact / representative items).

If you prefer, we can hide this whole section to keep the page “very high-impact only”.